ML 209

CAS No. 1334526-14-5

ML 209( —— )

Catalog No. M34963 CAS No. 1334526-14-5

ML-209 is an antagonist of retinoic acid receptor-related orphan receptor γt (RORγt; IC50= 1.1 μM in a reporter assay).1It inhibits RORγt-induced transcription in HEK293T cells expressing the human receptor (IC50= 300 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 141 Get Quote
5MG 211 Get Quote
10MG 275 Get Quote
25MG 434 Get Quote
50MG 632 Get Quote
100MG 849 Get Quote
500MG 1692 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    ML 209
  • Note
    Research use only, not for human use.
  • Brief Description
    ML-209 is an antagonist of retinoic acid receptor-related orphan receptor γt (RORγt; IC50= 1.1 μM in a reporter assay).1It inhibits RORγt-induced transcription in HEK293T cells expressing the human receptor (IC50= 300 nM).
  • Description
    (±)-ML 209 (compound 4n), a diphenylpropanamide, is a retinoic acid-related orphan receptor RORγ antagonist with an IC50 of 1.1 μM. (±)-ML 209 inhibits RORγt transcriptional activity with an IC50 of 300 nM in HEK293t cells. (±)-ML 209 inhibits the transcriptional activity of RORγt, but not RORα in cells. (±)-ML 209 selectively inhibits murine Th17 cell differentiation without affecting the differentiation of na ve CD4+ T cells into other lineages, including Th1 and regulatory T cells.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Nuclear Receptor/Transcription Factor
  • Target
    ROR
  • Recptor
    ROR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1334526-14-5
  • Formula Weight
    441.52
  • Molecular Formula
    C25H31NO6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(CC(=O)N1C[C@@H](C)C[C@@H](C)C1)(C2=C(OC)C=C(OC)C=C2O)C=3C=C4C(=CC3)OCO4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Jun R Huh, et al. Identification of Potent and Selective Diphenylpropanamide RORγ Inhibitors. ACS Med Chem Lett. 2013 Jan 10;4(1):79-84. ?
molnova catalog
related products
  • XY018

    XY018 is an orally available, selective and highly effective ROR-γ antagonist with antitumor activity, inhibits ROR-γ activity, inhibits tumor cell growth, and can be used to study drug-resistant prostate cancer.

  • Cedirogant

    Cedirogant is an orally active retinoid-related orphan receptor-γt(RORγt) inverse agonist that is used for psoriasis study.

  • TMP-778

    TMP-778 is a selective inverse agonist of RORγt.